// App-Quantinova.ai

2154 : TX1111: a peptide homologue of Topoisomerase-1 sensitizes pancreatic cancer cells to gemcitabine

Researchers

Presenter

  • Manu Gnanamony

Principal Investigators

  • Victoria Stepanova

  • Lily Criscione

  • Jerusha Boyineni

  • Stephen J. Marshall

  • Christopher S. Gondi

  • Ai

  • Xuan Holterman

Medical Centers

  • Univ. of Illinois College of Med. at Peoria, Peoria, IL.

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Topoisomerase-1

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved